Cited by 41Ginseng Biological Effects and ApplicationsSkin Protection and AgingGenomics, phytochemicals, and oxidative stress

Ginsenoside Rg1 attenuates ultraviolet B-induced glucocortisides resistance in keratinocytes via Nrf2/HDAC2 signalling

Open access
Li, Jun, Liu, Dong, Wu, Jinfeng, Zhang, Daniel, Cheng, Binbin, Zhang, Yani, Yin, Zifei, Wang, Yuan +2 more·2016·Scientific Reports

Abstract

Oxidative stress, which occurs after ultraviolet (UV) radiation, usually results in Glucocorticoid (GC) resistance and the subsequent development of skin inflammation. One approach to protecting the skin against UV radiation is the use of antioxidants. The ginsenoside Rg1 is a novel natural antioxidant isolated from the medicinal plant Panax ginseng C.A. Mey. We demonstrated that UVB exposure exacerbated inflammation and reduced both the level of the glucocorticoid receptor (GR) and the efficacy of dexamethasone (Dex) in human keratinocytes (HaCaT cells). Pretreatment with Rg1 increased the expression of GR and restored Dex responsiveness to inflammation in UVB-irradiated HaCaT cells. Mechanistically, Rg1 rescued UVB-induced HDAC2 degradation. HDAC2 knockdown partially abolished the Rg1-induced up-regulation of GR and the enhancement of GC sensitivity. In addition, Rg1 reduced the production of reactive oxygen species (ROS), which preceded the up-regulation of HDAC2, and consequent sensitization of cells to Dex. Moreover, Rg1 treatment promoted the translocation and activation of Nrf2. Nrf2 knockdown partially abolished the Rg1-induced decrease of ROS production and increase of HDAC2. Rg1 also potentiated the anti-inflammatory effects of Dex in UVB-irradiated mouse skin. In conclusion, we demonstrated that Rg1 attenuated UVB-induced GC insensitivity. Notably, these effects were partially mediated by the Nrf2/HDAC2 pathway.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep39336

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Ginsenoside Rg2 (1) and ginsenoside Rg1 (4) have exhibited anti-aging effects in Hs68 and HaCaT cells, respectively, related to a reduction in MMP-1 expression and ROS.

    “In previous studies, ginsenoside Rg2 (1) and ginsenoside Rg1 (4) have exhibited anti-aging effects in Hs68 and HaCaT cells, respectively. These were related to a reduction in MMP-1 expression and ROS [17,31].”

    From Anti-Aging and Anti-Inflammatory Effects of Compounds from Fresh Panax ginseng Roots: A Study on TNF-α/IFN-γ-Induced Skin Cell Damage (2024) · cites this paper as [31]

    The Results section, “Rg1 restored HDAC2 levels through ROS inhibition” (page unavailable), reports that Rg1 reduced UVB-induced ROS production in HaCaT keratinocytes. The paper investigates glucocorticoid resistance and skin inflammation, not an anti-aging effect in those cells; it does not report reduced MMP-1 expression. The Rg2/Hs68 finding is not attributed specifically to this source in the multiply cited sentence. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 49

  1. Maubec E.. Topical Mineralocorticoid Receptor Blockade Limits Glucocorticoid-Induced Epidermal Atrophy in Human Skin. The Journal of investigative dermatology 135, 1781– 1789, doi: 10.1038/jid.2015.44 (2015). 25668238 · DOI
  2. Ingawale D. K., Mandlik S. K. & Patel S. S. An emphasis on molecular mechanisms of anti-inflammatory effects and glucocorticoid resistance. Journal of complementary & integrative medicine 12, 1– 13, doi: 10.1515/jcim-2014-0051 (2015). 25503867 · DOI
  3. Yang N., Ray D. W. & Matthews L. C. Current concepts in glucocorticoid resistance. Steroids 77, 1041– 1049, doi: 10.1016/j.steroids.2012.05.007 (2012). 22728894 · DOI
  4. Ichihashi M.. UV-induced skin damage. Toxicology 189, 21– 39 (2003). 12821280
  5. Wu Z., Uchi H., Morino-Koga S., Shi W. & Furue M. Z-ligustilide ameliorated ultraviolet B-induced oxidative stress and inflammatory cytokine production in human keratinocytes through upregulation of Nrf2/HO-1 and suppression of NF-kappaB pathway. Experimental dermatology 24, 703– 708, doi: 10.1111/exd.12758 (2015). 25977183 · DOI
  6. Janjetovic Z.. Melatonin and its metabolites ameliorate ultraviolet B-induced damage in human epidermal keratinocytes. J Pineal Res 57, 90– 102, doi: 10.1111/jpi.12146 (2014). 24867336 PMC4106994 · DOI · Paper page
  7. Slominski A. T.. Local melatoninergic system as the protector of skin integrity. Int J Mol Sci 15, 17705– 17732, doi: 10.3390/ijms151017705 (2014). 25272227 PMC4227185 · DOI
  8. de Gruijl F. R. Photocarcinogenesis: UVA vs. UVB radiation. Skin pharmacology and applied skin physiology 15, 316– 320, doi: 64535 (2002). 12239425
  9. Slominski A. T., Manna P. R. & Tuckey R. C. On the role of skin in the regulation of local and systemic steroidogenic activities. Steroids 103, 72– 88, doi: 10.1016/j.steroids.2015.04.006 (2015). 25988614 PMC4631694 · DOI
  10. Slominski A. T.. Cytochromes p450 and skin cancer: role of local endocrine pathways. Anti-cancer agents in medicinal chemistry 14, 77– 96 (2014). 23869782 PMC3740756
  11. Skobowiat C., Sayre R. M., Dowdy J. C. & Slominski A. T. Ultraviolet radiation regulates cortisol activity in a waveband-dependent manner in human skin ex vivo. The British journal of dermatology 168, 595– 601, doi: 10.1111/bjd.12096 (2013). 23363016 PMC3586986 · DOI · Paper page
  12. Barnes P. J., Ito K. & Adcock I. M. Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet 363, 731– 733, doi: 10.1016/S0140-6736(04)15650-X (2004). 15001333 · DOI
  13. Hew M.. Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. American journal of respiratory and critical care medicine 174, 134– 141, doi: 10.1164/rccm.200512-1930OC (2006). 16614347 PMC2662905 · DOI
  14. Shakespear M. R., Halili M. A., Irvine K. M., Fairlie D. P. & Sweet M. J. Histone deacetylases as regulators of inflammation and immunity. Trends in immunology 32, 335– 343, doi: 10.1016/j.it.2011.04.001 (2011). 21570914 · DOI · Paper page
  15. Barnes P. J. Role of HDAC2 in the pathophysiology of COPD. Annu Rev Physiol 71, 451– 464, doi: 10.1146/annurev.physiol.010908.163257 (2009). 18817512 · DOI
  16. Ito K.. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. The Journal of experimental medicine 203, 7– 13, doi: 10.1084/jem.20050466 (2006). 16380507 PMC2118081 · DOI · Paper page
  17. Adenuga D.. Nrf2 deficiency influences susceptibility to steroid resistance via HDAC2 reduction. Biochem Biophys Res Commun 403, 452– 456, doi: 10.1016/j.bbrc.2010.11.054 (2010). 21094147 PMC3031165 · DOI
  18. Rangasamy T.. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. The Journal of clinical investigation 114, 1248– 1259, doi: 10.1172/JCI21146 (2004). 15520857 PMC524225 · DOI
  19. Malhotra D.. Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1. American journal of respiratory and critical care medicine 178, 592– 604, doi: 10.1164/rccm.200803-380OC (2008). 18556627 PMC2542433 · DOI
  20. Singh A.. Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs. Free radical biology & medicine 46, 376– 386, doi: 10.1016/j.freeradbiomed.2008.10.026 (2009). 19027064 PMC2828157 · DOI
  21. Sussan T. E.. Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice. Proceedings of the National Academy of Sciences of the United States of America 106, 250– 255, doi: 10.1073/pnas.0804333106 (2009). 19104057 PMC2629210 · DOI · Paper page
  22. Harvey C. J.. Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model. Science translational medicine 3, 78ra32, doi: 10.1126/scitranslmed.3002042 (2011). PMC4927975 21490276 · DOI
  23. Kensler T. W., Wakabayashi N. & Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47, 89– 116, doi: 10.1146/annurev.pharmtox.46.120604.141046 (2007). 16968214 · DOI · Paper page
  24. Kleszczynski K., Zillikens D. & Fischer T. W. Melatonin enhances mitochondrial ATP synthesis, reduces reactive oxygen species formation, and mediates translocation of the nuclear erythroid 2-related factor 2 resulting in activation of phase-2 antioxidant enzymes (gamma-GCS, HO-1, NQO1) in ultraviolet radiation-treated normal human epidermal keratinocytes (NHEK). J Pineal Res 61, 187– 197, doi: 10.1111/jpi.12338 (2016). 27117941 · DOI
  25. Saw C. L.. Nrf2 null enhances UVB-induced skin inflammation and extracellular matrix damages. Cell & bioscience 4, 39, doi: 10.1186/2045-3701-4-39 (2014). 25228981 PMC4164960 · DOI
  26. Jia L., Wang W. Y., Zhou L. M., Mo F. F. & Li M. Antimotion sickness effects of ginsenosides combined with dexamethasone in rats. Zhong xi yi jie he xue bao=Journal of Chinese integrative medicine 8, 358– 362, doi: 10.3736/jcim201090410 (2010). 20388477 · DOI
  27. Ru W.. Chemical constituents and bioactivities of Panax ginseng (C. A. Mey.). Drug Discov Ther 9, 23– 32, doi: 10.5582/ddt.2015.01004 (2015). 25788049 · DOI
  28. You Y. L.. Efficacy of ginsenosides combined with prednisone in patients with systemic lupus erythematosus: a prospective, randomized, double-blind, placebo-controlled trial. Zhong xi yi jie he xue bao=Journal of Chinese integrative medicine 8, 762– 766 (2010). 20727331
  29. Hu W.. The positive effects of Ginsenoside Rg1 upon the hematopoietic microenvironment in a D-Galactose-induced aged rat model. BMC Complement Altern Med 15, 119, doi: 10.1186/s12906-015-0642-3 (2015). 25881060 PMC4417299 · DOI
  30. Oh S. J., Oh Y., Ryu I. W., Kim K. & Lim C. J. Protective properties of ginsenoside Rb3 against UV-B radiation-induced oxidative stress in HaCaT keratinocytes. Biosci Biotechnol Biochem 80, 95– 103, doi: 10.1080/09168451.2015.1075862 (2015). 26287932 · DOI
  31. Li J.. Protective Effect of Ginsenoside Rg1 on Hematopoietic Stem/Progenitor Cells through Attenuating Oxidative Stress and the Wnt/beta-Catenin Signaling Pathway in a Mouse Model of d-Galactose-induced Aging. Int J Mol Sci 17, doi: 10.3390/ijms17060849 (2016). PMC4926383 27294914 · DOI
  32. Oh S. J., Kim K. & Lim C. J. Protective properties of ginsenoside Rb1 against UV-B radiation-induced oxidative stress in human dermal keratinocytes. Pharmazie 70, 381– 387 (2015). 26189299
  33. Binbin C., Yinglu F., Juan D. & Changquan L. Upregulation effect of ginsenosides on glucocorticoid receptor in rat liver. Hormone and metabolic research=Hormon- und Stoffwechselforschung=Hormones et metabolisme 41, 531– 536, doi: 10.1055/s-0029-1216373 (2009). 19418418 · DOI
  34. Radad K., Gille G., Moldzio R., Saito H. & Rausch W. D. Ginsenosides Rb1 and Rg1 effects on mesencephalic dopaminergic cells stressed with glutamate. Brain research 1021, 41– 53, doi: 10.1016/j.brainres.2004.06.030 (2004). 15328030 · DOI
  35. Lu J. M., Yao Q. & Chen C. Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol 7, 293– 302 (2009). 19601854 PMC2928028
  36. Kirkham P. & Rahman I. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacology & therapeutics 111, 476– 494, doi: 10.1016/j.pharmthera.2005.10.015 (2006). 16458359 · DOI
  37. Lee C. W.. Effect of Artocarpus communis Extract on UVB Irradiation-Induced Oxidative Stress and Inflammation in Hairless Mice. Int J Mol Sci 14, 3860– 3873, doi: 10.3390/ijms14023860 (2013). 23403620 PMC3588075 · DOI
  38. Salem S.. Transforming growth factor-beta impairs glucocorticoid activity in the A549 lung adenocarcinoma cell line. Br J Pharmacol 166, 2036– 2048, doi: 10.1111/j.1476-5381.2012.01885.x (2012). 22300324 PMC3402769 · DOI
  39. Kim H. K. Adenophora remotiflora protects human skin keratinocytes against UVB-induced photo-damage by regulating antioxidative activity and MMP-1 expression. Nutrition research and practice 10, 371– 376, doi: 10.4162/nrp.2016.10.4.371 (2016). 27478542 PMC4958638 · DOI
  40. Du J., Cheng B., Zhu X. & Ling C. Ginsenoside Rg1, a novel glucocorticoid receptor agonist of plant origin, maintains glucocorticoid efficacy with reduced side effects. J Immunol 187, 942– 950, doi: 10.4049/jimmunol.1002579 (2011). 21666059 · DOI
  41. Vedeckis W. V., Ali M. & Allen H. R. Regulation of glucocorticoid receptor protein and mRNA levels. Cancer Res 49, 2295s– 2302s (1989). 2702670
  42. Lonard D. M. & O’Malley B. W. Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation. Molecular cell 27, 691– 700, doi: 10.1016/j.molcel.2007.08.012 (2007). 17803935 · DOI
  43. Malhotra D.. Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis. Nucleic Acids Res 38, 5718– 5734, doi: 10.1093/nar/gkq212 (2010). 20460467 PMC2943601 · DOI
  44. Loboda A., Damulewicz M., Pyza E., Jozkowicz A. & Dulak J. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cellular and molecular life sciences: CMLS 73, 3221– 3247, doi: 10.1007/s00018-016-2223-0 (2016). 27100828 PMC4967105 · DOI
  45. To Y.. Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine 182, 897– 904, doi: 10.1164/rccm.200906-0937OC (2010). 20224070 PMC2970861 · DOI
  46. Song H. Y., Zhang L., Pan J. L., Yang L. L. & Ji G. Bioactivity of five components of Chinese herbal formula Jiangzhi granules against hepatocellular steatosis. Journal of integrative medicine 11, 262– 268, doi: 10.3736/jintegrmed2013034 (2013). 23867244 · DOI
  47. Ding D. F.. Mechanism of resveratrol on the promotion of induced pluripotent stem cells. Journal of integrative medicine 11, 389– 396, doi: 10.3736/jintegrmed2013039 (2013). 24125057 · DOI
  48. Ohkawa H., Ohishi N. & Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical biochemistry 95, 351– 358 (1979). 36810
  49. Ebaid H., Salem A., Sayed A. & Metwalli A. Whey protein enhances normal inflammatory responses during cutaneous wound healing in diabetic rats. Lipids in health and disease 10, 235, doi: 10.1186/1476-511X-10-235 (2011). 22168406 PMC3254143 · DOI

Cited by

Sorted by citations

Authors
Li, J., Liu, D., Wu, J., Zhang, D., Cheng, B., Zhang, Y., Yin, Z., Wang, Y., Du, J., & Ling, C.
Affiliations
  • Second Military Medical University (CN)
  • Fudan University (CN)
  • University of Florida Health (US)
Corresponding author
  • Du, Juan
  • Ling, Changquan
Venue
Scientific Reports
Published
2016-12-16
Volume
6
Issue
1
Pages
39336-39336
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2562433766
Cited by
41
References
7
Citations by year
2026: 4 · 2025: 5 · 2024: 4 · 2023: 3 · 2022: 7 · 2021: 2 · 2020: 9 · 2019: 6 · 2017: 1
FWCI
1.21
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Shanghai Municipal Education Commission (E03008)
  • E-Institutes of Shanghai Municipal Education Commission (E 03008, No E 03008)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ginseng Biological Effects and Applications
  • Health Sciences › Medicine › Dermatology › Skin Protection and Aging
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
Keywords
ginsenoside Rg1, UV-B radiation, glucocorticoid resistance, keratinocytes, Nrf2, HDAC2, glucocorticoid receptor, dexamethasone, oxidative stress, reactive oxygen species, skin inflammation, Panax ginseng, anti-inflammatory activity
MeSH terms
Antioxidants, Cells, Cultured, Dexamethasone, Glucocorticoids, Humans, Ultraviolet Rays, Signal Transduction, Keratinocytes, Reactive Oxygen Species, Oxidative Stress, Ginsenosides, NF-E2-Related Factor 2, Histone Deacetylase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review